After Hours
$
4.60
Change
-0.24 -4.96%
Volume
Volume 4,264
Feb 3, 2023, 7:50 p.m.
Quotes are delayed by 20 min
Today's close
$ 4.64
$ 4.84
Change
+0.20 +4.31%
Day low
Day high
$4.58
$5.00

52 week low
52 week high
$4.34
$15.38

Market cap
$273.64M
Average volume
172,767
P/E ratio
N/A
Rev. per Employee
$27,518
EPS
-2.24
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on IPSC
-
Chardan Research initiates coverage of Century Therapeutics with a buy rating and $19 price target
-
Century Therapeutics started at overweight with $40 stock price target at J.P. Morgan
- Tomi Kilgore
-
Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares
- Barron's Online
-
Century Therapeutics sets IPO terms; to offer 10.6 mln shares priced at $18 to $20 each
- Ciara Linnane
Other News on IPSC
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Athersys: Is Big Pharma Sleeping At The Wheel?
- Seeking Alpha
-
Century Therapeutics (IPSC) Investor Presentation - Slideshow
- Seeking Alpha
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Century Therapeutics (IPSC) Investor Presentation - Slideshow
- Seeking Alpha
-
10-Q: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Company Corporate Overview Presentation Apr 2022
- Seeking Alpha
-
10-K: CENTURY THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
What's Behind Bristol Myers Squibb's Latest Partnership?
- Motley Fool
- Loading more headlines...
Press Releases on IPSC
-
Century Therapeutics to Present at the SITC 37th Annual Meeting
- GlobeNewswire
-
Century Therapeutics to Present at Upcoming Investor Conferences
- GlobeNewswire
-
Century Therapeutics to Present at the ASGCT 25th Annual Meeting
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com